Skip to main content
Clinical Trials/CTRI/2018/05/014196
CTRI/2018/05/014196
Completed
Phase 2

Randomised Control Trial comparing the effects of Metformin to Myoinositol on ART outcome in women with PCOS undergoing IVF cycles

AIIMS0 sites102 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
AIIMS
Enrollment
102
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
March 15, 2020
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
AIIMS

Eligibility Criteria

Inclusion Criteria

  • ALL PCOS WOMEN RECRUITED FOR IVF

Exclusion Criteria

  • ENDOMETRIOSIS
  • ANY CONDITIONS COMPROMISING IMPLANTATION LIKE FIBROID
  • OVARIAN SURGERY
  • DERRANGED LFTs, KFTs
  • HYPERSENSITIVITY TO MYOINOSITOL
  • WOMEN WITH UNCONTROLLED THYROID DISEASE
  • PATIENTS UNDERGOING FROZEN EMBRYO TRANSFER

Outcomes

Primary Outcomes

Not specified

Similar Trials